Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: Evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent

Ge,Tingting; Yu,Qin; Liu,Wei; Cong,Li; Liu,Lizhen; Wang,Yan; Zhou,Liping; Lin,Deju

doi:10.3892/mmr.2016.4945

Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: Evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent

Authors:
- Tingting Ge
- Qin Yu
- Wei Liu
- Li Cong
- Lizhen Liu
- Yan Wang
- Liping Zhou
- Deju Lin
View Affiliations

Affiliations: Department of Bioengineering, College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Department of Pediatrics, The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Bone Marrow Transplantation Center, The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Published online on: February 29, 2016 https://doi.org/10.3892/mmr.2016.4945
Pages: 3498-3506
Copyright: © Ge et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The prolyl hydroxylase inhibitor dimethyloxallyl glycine (DMOG) has been increasingly studied with regards to stem cell therapy. Previous studies have demonstrated that endogenous mesenchymal stem cells (MSCs) may be mobilized into peripheral circulation by pharmaceutical preconditioning. In addition, our previous study confirmed that DMOG, as a novel mobilization agent, could induce mouse/rat MSC migration into peripheral blood circulation. Therefore, the present study conducted studies to characterize bone marrow‑derived MSCs (BM‑MSCs) collected from mice following DMOG intraperitoneal injection. The surface antigen immune phenotype, differentiation capability, proliferative ability, migratory capacity and paracrine capacity of the BM‑MSCs collected from DMOG‑preconditioned mice (DBM‑MSCs) or normal saline‑treated mice (NBM‑MSCs) were evaluated by means of flow cytometry, differentiation induction, Cell Counting kit‑8, Transwell assay and enzyme-linked immunosorbent assay, respectively. Compared with NBM‑MSCs, DBM-MSCs displayed a similar immune phenotype and multilineage differentiation capability, reduced proliferative ability and migratory capacity, and similar transforming growth factor and platelet-derived growth factor secretion capacity. These results provide a novel insight into the biological properties of BM‑MSCs from mice preconditioned with DMOG. DBM-MSCs exhibited slightly distinct characteristics to NBM-MSCs; however, they may have therapeutic potential for future stem cell therapy. In addition, the present study suggested that DMOG may be used as a novel mobilization agent in future clinical trials as no adverse effects were observed.

View Figures

View References

1	Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, et al: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:468–472. 2001. View Article : Google Scholar : PubMed/NCBI
2	Ockaili R, Salloum F, Natarajan R, Jones DG, Fisher BJ, Ghosh S, Fowler AA and Kukreja RC: Dimethyloxallyl glycine-A competitive inhibitor of prolyl hydroxylases induces cardioprotective effect via hypoxia inducible factor-1 alpha stabilization in rabbits. Circulation. 108:219. 2003.
3	Ding H, Gao YS, Wang Y, Hu C, Sun Y and Zhang CQ: Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential. Stem Cells Dev. 23:990–1000. 2014. View Article : Google Scholar :
4	Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS and Na KY: Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant. 25:77–85. 2010. View Article : Google Scholar
5	Milkiewicz M, Pugh CW and Egginton S: Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice. J Physiol. 560:21–26. 2004. View Article : Google Scholar : PubMed/NCBI
6	Yuan Q, Bleiziffer O, Boos AM, Sun J, Brandl A, Beier JP, Arkudas A, Schmitz M, Kneser U and Horch RE: PHDs inhibitor DMOG promotes the vascularization process in the AV loop by HIF-1a up-regulation and the preliminary discussion on its kinetics in rat. BMC Biotechnol. 14:1122014. View Article : Google Scholar : PubMed/NCBI
7	Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C and Buchan AM: Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 31:132–143. 2011. View Article : Google Scholar :
8	Liu XB, Wang JA, Ji XY, Yu SP and Wei L: Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats. Stem Cell Res Ther. 5:1112014. View Article : Google Scholar : PubMed/NCBI
9	Beyer Nardi N and da Silva Meirelles L: Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol. 174:249–282. 2006. View Article : Google Scholar
10	Deans RJ and Moseley AB: Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol. 28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
11	Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, et al: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 164:247–256. 2000. View Article : Google Scholar : PubMed/NCBI
12	Bianco P, Riminucci M, Gronthos S and Robey PG: Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells. 19:180–192. 2001. View Article : Google Scholar : PubMed/NCBI
13	Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T and Kaneda Y: Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 13:77–81. 2006. View Article : Google Scholar : PubMed/NCBI
14	Chunmeng S and Tianmin C: Skin: A promising reservoir for adult stem cell populations. Med Hypotheses. 62:683–688. 2004. View Article : Google Scholar : PubMed/NCBI
15	De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM and Luyten FP: Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160:909–918. 2003. View Article : Google Scholar
16	Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, Becchetti E, Marchionni C, Alviano F, Fossati V, et al: Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation. 80:836–842. 2005. View Article : Google Scholar : PubMed/NCBI
17	Yamada Y, Fujimoto A, Ito A, Yoshimi R and Ueda M: Cluster analysis and gene expression profiles: A cDNA microarray system-based comparison between human dental pulp stem cells (hDPSCs) and human mesenchymal stem cells (hMSCs) for tissue engineering cell therapy. Biomaterials. 27:3766–3781. 2006. View Article : Google Scholar : PubMed/NCBI
18	Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL and Chen TH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 103:1669–1675. 2004. View Article : Google Scholar
19	Pitchford SC, Hahnel MJ, Jones CP and Rankin SM: Troubleshooting: Quantification of mobilization of progenitor cell subsets from bone marrow in vivo. J Pharmacol Toxicol Methods. 61:113–121. 2010. View Article : Google Scholar : PubMed/NCBI
20	Alhadlaq A and Mao JJ: Mesenchymal stem cells: Isolation and therapeutics. Stem Cells Dev. 13:436–448. 2004. View Article : Google Scholar : PubMed/NCBI
21	Lazarus HM, Haynesworth SE, Gerson SL and Caplan AI: Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections. J Hematother. 6:447–455. 1997.PubMed/NCBI
22	Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B and Hows JM: Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 121:368–374. 2003. View Article : Google Scholar : PubMed/NCBI
23	Roufosse CA, Direkze NC, Otto WR and Wright NA: Circulating mesenchymal stem cells. Int J Biochem Cell Biol. 36:585–597. 2004. View Article : Google Scholar : PubMed/NCBI
24	Neth P, Ciccarella M, Egea V, Hoelters J, Jochum M and Ries C: Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells. 24:1892–1903. 2006. View Article : Google Scholar : PubMed/NCBI
25	Kumar S and Ponnazhagan S: Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone. 50:1012–1018. 2012. View Article : Google Scholar : PubMed/NCBI
26	Deng J, Zou Z, Zhou T, Ai G, Wang J, Dong S and Su S: The mobilization of rat mesenchymal stem cells into peripheral blood by LiCL and its potency differentiation. Chinese Science Bulletin. 53:2632–2638. 2008.
27	Liu W, Yu Q, Liu L, Zhou L and Hu S: Effect of prolylhydroxylase inhibitor on mobilization of mesenchymal stem cells in mice. Zhejiang Zhongyiyaodaxue Xuebao. 37:1371–1376. 2013.In Chinese.
28	Hu S, Yu Q, Liu L and Ge T: Mechanism of HIF-1 signaling pathway in mediating MSCs mobilization with DMOG. Zhongguo Bijiaoyixue Zazhi. 25:9–14. 2014.In Chinese.
29	National Research Council: Guide for the care and use of laboratory animals. 7th edition. National Academies Press; Washington, DC: 1996
30	Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I and Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 98:2396–2402. 2001. View Article : Google Scholar : PubMed/NCBI
31	Liu L, Yu Q, Lin J, Lai X, Cao W, Du K, Wang Y, Wu K, Hu Y, Zhang L, et al: Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 20:1961–1971. 2011. View Article : Google Scholar : PubMed/NCBI
32	Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O₂ sensing. Science. 292:464–468. 2001. View Article : Google Scholar : PubMed/NCBI
33	Noort WA, Oerlemans MIFJ, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijikens B, Martens AC, Bühring HJ, Doevendans PA and Sluijter JPG: Human versus porcine mesenchymal stromal cells: Phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med. 16:1827–1839. 2011. View Article : Google Scholar : PubMed/NCBI
34	Lv FJ, Tuan RS, Cheung KM and Leung VY: Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells. 32:1408–1419. 2014. View Article : Google Scholar : PubMed/NCBI
35	Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, Belmonte N, Ferrari G, Leone BE, Bertuzzi F, et al: Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 106:419–427. 2005. View Article : Google Scholar : PubMed/NCBI
36	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
37	Laudes M: Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol. 46:R65–R72. 2011.PubMed/NCBI
38	Cristancho AG and Lazar MA: Forming functional fat: A growing understanding of adipocyte differentiation. Nat Rev Mol. Cell Biol. 12:722–734. 2011.
39	Lin GL and Hankenson KD: Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem. 112:3491–3501. 2011. View Article : Google Scholar : PubMed/NCBI
40	Wang W, Li B, Yang J, Xin L, Li Y, Yin H, Qi Y, Jiang Y, Ouyang H and Gao C: The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. Biomaterials. 31:8964–8973. 2010. View Article : Google Scholar : PubMed/NCBI
41	Hirao M, Tamai N, Tsumaki N, Yoshikawa H and Myoui A: Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem. 281:31079–31092. 2006. View Article : Google Scholar : PubMed/NCBI
42	Guo W, Qian L, Zhang J, Zhang W, Morrison A, Hayes P, Wilson S, Chen T and Zhao J: Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res. 89:1723–1736. 2011. View Article : Google Scholar : PubMed/NCBI
43	Schultz K, Murthy V, Tatro JB and Beasley D: Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms. Am. J Physiol Lung Cell Mol Physiol. 296:L921–L927. 2009. View Article : Google Scholar
44	Liu XB, Wang JA, Ogle ME and Wei L: Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem. 106:903–911. 2009. View Article : Google Scholar : PubMed/NCBI
45	Yu Q, Liu L, Lin J, Wang Y, Xuan X, Guo Y and Hu S: SDF-1α/CXCR4 axis mediates the migration of mesenchymal stem cells to the hypoxic-ischemic brain lesion in a rat model. Cell J. 16:440–447. 2015.PubMed/NCBI
46	Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, et al: Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
47	Wang Y, Fu W, Zhang S, He X, Liu Z, Gao D and Xu T: CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reper-fusion rat hippocampus. Brain Res. 1575:78–86. 2014. View Article : Google Scholar : PubMed/NCBI
48	Hu C, Yong X, Li C, Lü M, Liu D, Chen L, Hu L, Teng M, Zhang D, Fan Y and Liang G: CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J Surg Res. 183:427–434. 2013. View Article : Google Scholar : PubMed/NCBI
49	Doorn J, Moll G, Le Blanc K, van Blitterswijk C and de Boer J: Therapeutic applications of mesenchymal stromal cells: Paracrine effects and potential improvements. Tissue Eng Part B Rev. 18:101–115. 2012. View Article : Google Scholar
50	Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS and Tanavde V: PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 112:295–307. 2008. View Article : Google Scholar : PubMed/NCBI